NIH-funded research Career grant

Understanding how high blood sugar affects insulin-producing cells

Official title: Pancreatic beta-cell glucose toxicity and mRNA translation

Funded at Joslin Diabetes Center · NIH-10947979 · Data updated 2026-11-12

This study looks at how long-term high blood sugar affects the insulin-making cells in the pancreas, which could help people with type 1 diabetes understand how their blood sugar levels impact their insulin production and health.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionJoslin Diabetes Center
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$91,500
NIH project number1K99DK140526-01
Project IDNIH-10947979 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with type 1 diabetes or those experiencing beta-cell dysfunction due to chronic high glucose levels.

Less likely to help

Patients without any form of diabetes or those whose beta-cell function is not affected by glucose levels may not benefit from this research.

What this research studies

This research investigates how chronic high glucose levels impact the function of pancreatic beta-cells, which are responsible for insulin production. By using advanced techniques like ribosome profiling and proteomics, the study aims to identify changes in mRNA translation that occur when these cells are exposed to sustained high glucose. The findings could help clarify the mechanisms behind beta-cell dysfunction, particularly in conditions like type 1 diabetes. Patients may gain insights into how their blood sugar levels affect their insulin production and overall health.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preserving insulin production in patients with diabetes.

How similar studies have gone: Previous research has shown that understanding cellular responses to glucose can lead to significant advancements in diabetes treatment, indicating that this approach has potential for success.

Where this research is happening

  • Joslin Diabetes Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Cheruiyot, Abigael — Joslin Diabetes Center
  • Study coordinator: Cheruiyot, Abigael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.